Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Construction of brest cancer cell line BT20-specific interactome
PubMed Full text in PMC Similar studies
Genome-wide survey of adjacent gene rearrangements in breast cancer identifies triple-negative specific BCL2L14-ETV6 fusions
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Expression data from triple negative breast cancer cells
PubMed Full text in PMC Similar studies Analyze with GEO2R
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing
Expression data from NMuMG-mock cells and NMuMG-MAFK cells
PubMed Similar studies Analyze with GEO2R
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
Discovery of biomarkers predictive of GSI response in triple negative breast cancer and adenoid cystic carcinoma
Profiling of human cancer breast cell lines (Affymetrix)
Basal epithelial subpopulations underlie and predict chemotherapy resistance in Triple-Negative Breast Cancer
Characterizing the heterogeneity of triple-negative breast cancers using RNA Sequencing
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics [RNA-seq]
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics [ChIP-seq]
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer
RNA-sequencing for the characterization of the transcriptome of SUM 159 parental and Paclitaxel (PTX) resistant breast cancer cells.
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer
Etv6-dependent positive and negative gene regulatory network controls vegfa expression in vivo
Etv6-dependent positive and negative gene regulatory network controls vegfa expression in vivo [ChIP-seq]
PubMed Full text in PMC Similar studies SRA Run Selector
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on